Shanghai Rivershine

Shanghai Righton Biotechnology (Righton Bio) is a leading Chinese molecular diagnostics company specializing in precision medicine for oncology and hematology. The company develops and commercializes a comprehensive portfolio of in vitro diagnostic (IVD) kits based on PCR, NGS, and FISH technologies, with a dominant market position in the Chinese leukemia diagnostic sector. Righton Bio provides essential tools for fusion gene detection, mutation analysis, and minimal residual disease (MRD) monitoring, supporting early screening and companion diagnostics. Listed on the Shanghai Stock Exchange Star Market, the company operates high-standard GMP manufacturing facilities and maintains extensive collaborations with major clinical centers across China.